Columbia University

Technology Ventures

Pfizer CTI RFP Informational Session

October 16, 2018
Nader Halim
Hammer Health Sciences Center Room 312
701 W 168th St
New York, NY

Date + Times: 

  • Tuesday, October 16th 11:00 AM - Group informational session/presentation at Hammer Health Sciences Building Room 312, 701 W 168th St
  • Tuesday, October 16th 12:15 AM - 5:00 PM - 30 minute one-on-one meetings at Columbia Technology Ventures office, 51 Audobon Street, 2nd floor REQUIRED PRE-REGISTRATION (book here).

Overview: Nader Halim, PhD, Senior Director of Pfizer's External Science and Innovation team, will be offering an informational session followed by office hours, to meet with researchers interested in applying for the Pfizer CTI Call for Preproposals. The 10:00 AM informational session is open to the public and does not require registration. From 12:15 PM onward, Nader will offer 30 minute one-on-one meetings with interested teams. Pre-registration is required and can be booked here.

Bio: Nader Halim is a member of Pfizer’s External Science & Innovation (ES&I) team and is a scientific liaison to academic intuitions, biotechnology companies, and venture capital firms in New York City and the Mid-Atlantic region .  Prior to his role in ES&I Nader was a member of Pfizer’s Global Policy Team where he focused on issues related to biologics, coding, coverage, and reimbursement.  Prior to joining Pfizer Nader was a life science focused consultant where he lead teams and projects in multiple functional areas including market access, commercial, strategy and portfolio operations, health economics, and supply chain management. These projects spanned the life sciences spectrum including pharmaceuticals, healthcare based technology, medical devices, and diagnostics.  He received his B.S. in biology from San Diego State University and a Ph.D. in molecular and cellular biology from the National Institutes of Health and the Uniformed Services University of the Health Sciences.  He also completed his joint M.B.A and M.P.H. at Johns Hopkins University focused on the intersection of public health and healthcare.